Updated Tuesday, September 26, 2017
 Journal Tools
RSS Feed
Sample Copy
Submit a Manuscript
Contact Us
Thanking Peer Reviewers
 Language Polishing
Journal of Chinese Integrative Medicine: Volume 10, 2012   Issue 10,  Pages: 1162-1170

DOI: 10.3736/jcim20121014
Original Experimental Research
Synergistic effects of ethyl acetate fraction of Ficus septica Burm. f. and doxorubicin chemotherapy on T47D human breast cancer cell line
1. Agung E. Nugroho (Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Jogjakarta 55281, Indonesia E-mail: E-mail: agungendronugroho@yahoo.com)
2. Adam Hermawan (Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Jogjakarta 55281, Indonesia )
3. Dyaningtyas D. P. Putri (Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Jogjakarta 55281, Indonesia )
4. Edy Meiyanto (Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Jogjakarta 55281, Indonesia )
5. Lukman Hakim (Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Jogjakarta 55281, Indonesia )
OBJECTIVE: Previously, ethanolic extract of Ficus septica Burm. f. (Moraceae) leaves and its ethyl acetate soluble fraction (EASF) exhibited potent cytotoxic effects on T47D breast cancer cells. In the present study, we further investigated the effects of EASF of ethanolic extract of F. septica leaves in combination with doxorubicin on T47D breast cancer cell line in cytotoxicity, cell cycle arrest and apoptosis induction.
METHODS: The cytotoxic effect analysis on T47D cells was carried out using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Analysis of cell cycle distribution was performed using a flowcytometer and the data were analyzed using ModFit LT 3.0 program. Apoptosis assay was carried out by double staining method using ethydium bromide-acridin orange. The expression of cleaved-poly ADP-ribose polymerase in the T47D cell line was identified using immunohistochemical techniques.
RESULTS: The combination of doxorubicin (2 to 8 nmol/L) with EASF (0.875 to 7 μg/mL) more potently inhibited cell growth than the single treatment of doxorubicin in T47D cells. In addition, the combination of doxorubicin and EASF could increase the incidence of cells undergoing apoptosis. EASF was found to improve cytotoxic effect of doxorubicin by changing the inhibition of cell cycle G2/M to G1 phase. The combination also exhibited a more intensive stimulatory effect on cleaved-PARP expression in T47D cells than the single treatment.
CONCLUSION: It is concluded that EASF may enhance doxorubicin activities in T47D cells by inducing apoptosis and cell cycle arrest.
Welcome to JIM! You are the number 10161 reader of this article!
Download Article:
[Full Text]      [PDF]      [Previous]      [Next]      [This Issue]
Please cite this article as:
Nugroho AE, Hermawan A, Putri DDP, Meiyanto E, Hakim L. Synergistic effects of ethyl acetate fraction of Ficus septica Burm. f. and doxorubicin chemotherapy on T47D human breast cancer cell line. J Chin Integr Med / Zhong Xi Yi Jie He Xue Bao. 2012; 10(10): 1162-1170.
1Hanahan D, Weinberg RA. The hallmarks of cancer[J].Cell, 2000, 100(1): 57-70.  
2Rang HP, Dale MM, Ritter JM, Moore PK. Pharmacology. 5th ed[M]. London: Churchill Livingstone, 2003. 693-698.  
3World Health Organization. Cancer. (2012-02) [2012-02-15]. http://www.who.int/mediacentre/factsheets/fs297/en/.
4Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010[J].CA Cancer J Clin, 2010, 60(5): 277-300.  
5Stuckey A. Breast cancer: epidemiology and risk factors[J].Clin Obstet Gynecol, 2011, 54(1): 96-102.  
6Mazumdar M, Fournier D, Zhu DW, Cadot C, Poirier D, Lin SX. Binary and ternary crystal structure analyses of a novel inhibitor with 17β-HSD type 1: a lead compound for breast cancer therapy[J].Biochem J, 2009, 424(3): 357-366.  
7Jin H, Zangar RC. Protein modifications as potential biomarkers in breast cancer[J].Biomark Insights, 2009, 4: 191-200.  
8Tjindarbumi D, Mangunkusumo R. Cancer in Indonesia, present and future[J].Jpn J Clin Oncol, 2002, 32(Suppl): S17-S21.  
9Todorova I, Simeonova G, Simeonov R, Dinev D. Efficacy and toxicity of doxorubicin and cyclophosphamide chemotherapy in dogs with spontaneous mammary tumours[J].Trakia J Sci, 2005, 3(5): 51-58.  
10Greidanus J, Willemse PH, Uges DR, Oremus ET, De Langen ZJ, De Vries EG. Continuous infusion of low-dose doxorubicin, epirubicin and mitoxantrone in cancer chemotherapy: a review[J].Pharm Weekbl Sci, 1988, 10(6): 237-245.  
11Ficus septica Burm. F. on human breast cancer T47D cell lines[J].Int J Phytomedicine, 2011, 3(2): 216-226.  
12Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays[J].J Immunol Methods, 1983, 65(1-2): 55-63.  
13Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors[J].Adv Enzyme Regul, 1984, 22: 27-55.  
14Hermawan A, Meiyanto E, Susidarti RA. Hesperidin increases cytotoxic activity of doxorubicin on MCF-7 cells[J].Indones J Pharm, 2010, 21(1): 8-17.  
15Meiyanto E, Fitriasari A, Hermawan A, Junedi S, Susidarti RA. The improvement of doxorubicin activity on breast cancer cell lines by tangeretin through cell cycle modulation[J].Orient Pharm Exp Med, 2011, 11(3): 183-190.  
16Haryanti S, Junedi S, Meiyanto E. Ethanolic extract of Hedyotis corymbosa L. increases cytotoxic activity of doxorubicin on MCF-7 breast cancer cell[J].Indones J Biotech, 2009, 14(1): 1146-1154.  
17Kumala S, Septiseptyana EP, Meiyanto E. Cytotoxic effect of secondary metabolites produced by endopytic fungi 1.3.11, 1.1.6 and 1.2.6 isolated from the fruit of “Tanaman Buah Makassar” (Brucea janvanica L. Merr) on in-vitro T47D and MCF-7 intact cells and identification of the fungus 1.3.11 by ribosomal DNA sequence analysis[J].Int J Pharm Pharm Sci, 2010, 2(2): 80-83.  
18Nurrochmad A, Lukitaningsih E, Meiyanto E. Anticancer activity of rodent tuber (Thyphonium flagelliforme (lodd.) Blume) on human breast cancer T47D cells[J].Int J Phytomedicine, 2011, 3(1): 138-146.  
19Meiyanto E, Handayani S, Susidarti RA, Jenie RI. Chloroform fraction of Areca (Areca catechu L.) induces apoptosis and decreases Bcl-2 expression on MCF-7 cells[J].Artocarpus, 2008, 8(2): 55-59.  
20Meiyanto E, Handayani S, Jenie RI. Snake beans (Vigna sinensis (L) Savi ex Hassk) extract increases breast epithelial cells proliferation[J].Indones J Pharm, 2008, 19(4): 191-197.  
21Pebriana RB, Wardhani BWK, Widayanti E, Wijayanti NLS, Wijayanti TR, Riyanto S, Meiyanto E. Apoptotic effect of Kenikir leaves (Cosmos caudatus Kunth.) methanolic extract on breast cancer cell line[J].Pharmacon, 2008, 9(1): 21-26.  
22Di Leo A, Tanner M, Desmedt C, Paesmans M, Cardoso F, Durbecq V, Chan S, Perren T, Aapro M, Sotiriou C, Piccart MJ, Larsimont D, Isola J; TAX 303 translational study team. p-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase Ⅲ clinical trial[J].Ann Oncol, 2007, 18(6): 997-1003.  
23Vayssade M, Haddada H, Faridoni-Laurens L, Tourpin S, Valent A, Bénard J, Ahomadegbe JC. P73 functionally replaces p53 in adriamycin-treated, p53-deficient breast cancer cells[J].Int J Cancer, 2005, 116(6): 860-869.  
24Rudin CM, Thompson CB. Apoptosis and disease: regulation and clinical relevance of programmed cell death[J].Annu Rev Med, 1997, 48: 267-281.  
25Grimm D, Wehland M, Pietsch J, Infanger M, Bauer J. Drugs interfering with apoptosis in breast cancer[J].Curr Pharm Des, 2011, 17(3): 272-283.  
26Kumar R, Vadlamudi RK, Adam L. Apoptosis in mammary gland and cancer[J].Endocr Relat Cancer, 2000, 7(4): 257-269.  
27Fan TJ, Han LH, Cong RS, Liang J. Caspase family proteases and apoptosis[J].Acta Biochim Biophys Sin (Shanghai), 2005, 37(11): 719-727.  
28Sodhi RK, Singh N, Jaggi AS. Poly (ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications[J].Vascul Pharmacol, 2010, 53(3-4): 77-87.  
29Peralta-Leal A, Rodríguez MI, Oliver FJ. Poly (ADP-ribose) polymerase-1 (PARP-1) in carcinogenesis: potential role of PARP inhibitors in cancer treatment[J].Clin Transl Oncol, 2008, 10(6): 318-323.  
30Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G, Iyer S, Smulson M. Role of poly (ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells[J].J Biol Chem, 1999, 274(33): 22932-22940.  
31Rios J, Puhalla S. PARP inhibitors in breast cancer: BRCA and beyond[J].Oncology (Williston Park), 2011, 25(11): 1014-1025.  
32Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity[J].Pharmacol Rev, 2004, 56(2): 185-229.  
33Kim JB, Yu JH, Ko E, Lee KW, Song AK, Park SY, Shin I, Han W, Noh DY. The alkaloid berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest[J].Phytomedicine, 2010, 17(6): 436-440.  
34Wu PL, Rao KV, Su CH, Kuoh CS, Wu TS. Phenanthroindolizidine alkaloids and their cytotoxicity from the leaves of Ficus septica. Heterocycles. 2002; 57(12): 2401-2408.
35Ueda JY, Takagi M, Shin-ya K. Aminocaprophenone- and pyrrolidine-type alkaloids from the leaves of Ficus septica. J Nat Prod. 2009; 72(12): 2181-2183.
36Damu AG, Kuo PC, Shi LS, Li CY, Kuoh CS, Wu PL, Wu TS. Phenanthroindolizidine alkaloids from the stems of Ficus septica. J Nat Prod. 2005; 68(7): 1071-1075.
37Damu AG, Kuo PC, Shi LS, Li CY, Su CR, Wu TS. Cytotoxic phenanthroindolizidine alkaloids from the roots of Ficus septica. Planta Med. 2009; 75(10): 1152-1156.
 Home | Current Issue | Past Issues | SearchRSS
Copyright © 2013-2018 by JIM Editorial Office. All rights reserved. ISSN 2095-4964; CN 31-2083/R. 沪ICP备110264号